- Joined
- 24 May 2009
- Posts
- 1,576
- Reactions
- 1,453
Let's look at their early testing which is now in phase two trials. they gave it to a guy who had had 30 treatments of chemo and was somehow still alive and very resitant to treatment. It worked.
They have found also that the dose is low, below predicted before the drug worked. This is a big deal.
Trials are taking place in the UK. I sense is a real buzz with some of the big pharmas.
Looks like some of this detail is highlighted, along with other detail in the latest ASX release Knobby. If I read this right the patients seem to be suffering long term chronic conditions as a 'prerequisite' for selection. Phase 2 is underway and with continued great news will hopefully get a lot more big pharma interest and maybe see some good growth.
Well, I'm hoping anyways.
https://www.asx.com.au/asxpdf/20191210/pdf/44cfvf8bnfs5vm.pdf
Well if they come back with another round of good results then that bounce will probably be much more impressive. There are so many 'promising' cures out there who knows what is going to be that magic elixir. Some of it very dubious and hard to believe!!Well that burst didn't last.
If there is anything in it, it might bounce back.
Stocking up on shares? Or products for the US black market?Wondering if I should buy more.
Is this you buying more Knobby?Yes, definite accumulation taking place.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?